For most people, HSV-1 is a mild, manageable infection. Roughly two-thirds of the global population under age 50 carries it, and the majority never develop noticeable symptoms. That said, “not bad for most people” isn’t the same as “harmless for everyone.” The virus stays in your body permanently, can reactivate periodically, and in rare cases causes serious complications. Understanding what’s typical and what’s unusual helps put HSV-1 in perspective.
Most People With HSV-1 Never Know They Have It
HSV-1 is overwhelmingly common. Billions of people worldwide are infected, many of them since childhood after contact with a family member’s saliva. Most carriers are completely asymptomatic, meaning they never get a cold sore or any other visible sign. The virus quietly takes up residence in nerve cells near the base of the skull and can remain dormant for years or even a lifetime.
Even among people who never notice symptoms, the virus periodically reactivates and reaches the skin surface. Studies using sensitive DNA detection methods found that over 70% of carriers shed HSV-1 from the mouth at least once a month, and many shed the virus more than six times per month. Individual shedding rates vary enormously, from nearly zero to over 90% of days tested. These brief shedding episodes are how the virus spreads so widely without most people realizing they’re contagious.
What a First Outbreak Looks Like
When a primary HSV-1 infection does cause symptoms, it tends to be the worst episode you’ll ever have. In children, this often shows up as painful, swollen gums and small ulcers on the tongue, inner cheeks, and lips, sometimes accompanied by a fever as high as 104°F. The acute phase lasts five to seven days, with full resolution in about two weeks. Adults experiencing a first oral infection may instead get a severe sore throat with ulcers on the tonsils, along with fever, headache, and fatigue.
A first genital HSV-1 outbreak follows a similar pattern: painful ulcers that persist for roughly 4 to 15 days before crusting over and healing. Viral shedding during a primary genital episode lasts a median of about 12 days. Primary infections at any site can also cause tender, swollen lymph nodes nearby.
Recurrent Outbreaks Are Milder
After the first episode, recurrences are shorter and less painful. A typical cold sore recurrence starts with a tingling or burning sensation at the usual spot, followed by a small cluster of blisters that ulcerate and heal within about four to six days. Peak viral shedding happens in the first 24 hours but can last up to five days.
How often recurrences happen varies widely from person to person. Some people get multiple cold sores a year, others go years between episodes, and many never get a second one. Triggers commonly include stress, illness, sun exposure, and fatigue. Genital HSV-1 recurs far less frequently than genital HSV-2. The CDC notes that both recurrences and subclinical shedding are much lower with genital HSV-1 than with HSV-2, which is an important distinction if you’ve been diagnosed with genital HSV-1 specifically.
Antiviral Treatment Helps but Doesn’t Cure
No treatment eliminates HSV-1 from the body, but antiviral medication meaningfully shortens outbreaks. In a trial of children with primary oral herpes, antiviral treatment reduced fever from three days to one, cut lesion duration from 10 days to four, and shortened viral shedding from five days to one. For recurrent cold sores, starting antiviral treatment at the first sign of tingling shortens healing time by roughly one to two days compared to doing nothing. Even a single day of high-dose treatment at the first prodromal symptoms has been shown to be as effective as a two-day course.
Topical antiviral creams are also available over the counter. Applied every two hours during the day, they modestly reduce healing time (about half a day faster) and slightly shorten the pain period. For people who get frequent recurrences, daily suppressive antiviral therapy can reduce outbreak frequency significantly.
Rare but Serious Complications
The vast majority of HSV-1 cases stay confined to cold sores or mild genital outbreaks. In rare instances, however, the virus causes problems that are genuinely dangerous.
Herpes Simplex Encephalitis
HSV-1 is the most common cause of sporadic (non-epidemic) fatal encephalitis. It strikes roughly 2 people per million per year in the United States. Without treatment, it kills about 70% of those affected and leaves most survivors with severe neurological damage. With prompt antiviral treatment, mortality drops to somewhere between 6% and 19%. This is exceedingly rare, but it’s the reason sudden confusion, seizures, or personality changes alongside a fever warrant emergency attention.
Eye Infections
HSV-1 can infect the cornea, a condition called herpetic keratitis. Globally, an estimated 230,000 people develop new vision impairment from this complication each year. Recurrent eye infections can cause progressive corneal scarring. If you notice eye pain, light sensitivity, or blurred vision during an HSV-1 outbreak, that needs prompt evaluation.
Neonatal Herpes
Newborns exposed to active herpes lesions during delivery can develop serious systemic infections. The risk is highest when a mother acquires a new HSV infection near the time of delivery, because she hasn’t yet developed antibodies that would partially protect the baby. Neonatal herpes is uncommon but can be life-threatening, which is why obstetricians screen for active lesions before vaginal delivery.
The Alzheimer’s Connection
A growing body of research links HSV-1 to a modestly increased risk of Alzheimer’s disease. A systematic review and meta-analysis found that HSV-1 carriers had 46% higher odds of developing Alzheimer’s compared to non-carriers, based on case-control data. Cohort studies showed a 20% increased risk. Interestingly, HSV-2 did not show the same association. The theory is that repeated viral reactivation in nerve tissue may contribute to the kind of inflammation and protein buildup seen in Alzheimer’s brains. This doesn’t mean HSV-1 causes Alzheimer’s, and the absolute increase in risk for any individual is small, but it’s an area of active scientific interest.
The Emotional Side Can Be Worse Than the Physical
For many people, the hardest part of an HSV-1 diagnosis (especially genital HSV-1) isn’t the sores themselves. It’s the stigma. In a study of women newly diagnosed with genital herpes, 34% met clinical thresholds for depression and 64% qualified as anxiety cases. A majority reported feeling ashamed and worried about transmitting the virus to partners. This psychological burden is real and often disproportionate to the physical severity of the condition.
The gap between how serious HSV-1 actually is medically and how devastating the diagnosis feels emotionally is one of the most notable things about this virus. Billions of people carry it, most without knowing. The physical symptoms, when they occur at all, are typically mild and treatable. Yet the cultural weight attached to a herpes diagnosis can cause genuine distress that persists long after an outbreak heals. If you’re struggling with a new diagnosis, that reaction is common and doesn’t reflect how much this virus will actually affect your daily life going forward.